X-linked Charcot-Marie-Tooth disease - definizione. Che cos'è X-linked Charcot-Marie-Tooth disease
Diclib.com
Dizionario ChatGPT
Inserisci una parola o una frase in qualsiasi lingua 👆
Lingua:

Traduzione e analisi delle parole tramite l'intelligenza artificiale ChatGPT

In questa pagina puoi ottenere un'analisi dettagliata di una parola o frase, prodotta utilizzando la migliore tecnologia di intelligenza artificiale fino ad oggi:

  • come viene usata la parola
  • frequenza di utilizzo
  • è usato più spesso nel discorso orale o scritto
  • opzioni di traduzione delle parole
  • esempi di utilizzo (varie frasi con traduzione)
  • etimologia

Cosa (chi) è X-linked Charcot-Marie-Tooth disease - definizione


X-linked Charcot-Marie-Tooth disease         
CHARCOT-MARIE-TOOTH DISEASE THAT HAS MATERIAL BASIS IN X-LINKED INHERITANCE OF A POINT MUTATION IN THE CONNEXIN-32 GENE
Draft:X-linked Charcot-Marie-Tooth disease; X-linked Charcot-Marie-Tooth disease
X-linked Charcot-Marie-Tooth disease is a group of genetic disorders and a type of Charcot-Marie-Tooth disease characterized by sensory loss associated with muscle weakness and atrophy alongside many other symptoms.
CharcotMarieTooth disease classifications         
Classifications of CharcotMarieTooth disease refers to the types and subtypes of CharcotMarieTooth disease (CMT), a genetically and clinically heterogeneous group of inherited disorders of the peripheral nervous system characterized by progressive loss of muscle tissue and touch sensation across various parts of the body. CMT is a result of genetic mutations in a number of genes.
X-linked lymphoproliferative disease         
LYMPHOPROLIFERATIVE DISORDER
Duncan's disease; X-linked lymphoproliferative syndrome; Purtilo syndrome; XLP (hematology)
X-linked lymphoproliferative disease (also known as Duncan disease or Purtilo syndrome and abbreviated as XLP) is a lymphoproliferative disorder, usually caused by SH2DIA gene mutations in males. XLP-positive individuals experience immune system deficiencies that render them unable to effectively respond to the Epstein-Barr virus (EBV), a common virus in humans that typically induces mild symptoms or infectious mononucleosis (IM) in patients.